KIR gene haplotype: an independent predictor of clinical outcome in MDS patients-Reference-Cited by-同舟云学术

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

Published:2016-12-15 Issue:24 Volume:128 Page:2819-2823
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Stringaris Kate¹,Marin David²,Barrett A. John³,Hills Robert⁴,Sobieski Catherine²,Cao Kai²,Saltarrelli Jerome G.²,Daher May²,Shaim Hila²,Smith Nathaniel²,Linch David⁵,Gale Rosemary⁵,Allen Christopher⁵,Sekine Takuya²,Mehta Rohtesh²,Champlin Richard²,Shpall Elizabeth J.²,Kantarjian Hagop⁶,Garcia-Manero Guillermo⁶,Rezvani Katayoun²

Affiliation:

1. Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom;

2. Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX;

3. Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;

4. Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, United Kingdom;

5. Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom; and

6. Leukemia Department, MD Anderson Cancer Center, Houston, TX

Abstract

Key Points KIR haplotype A is an independent risk factor for the progression of MDS to AML.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/128/24/2819/1358024/blood713099.pdf

Reference23 articles.

1. Targeting natural killer cells and natural killer T cells in cancer;Vivier;Nat Rev Immunol,2012

2. Up on the tightrope: natural killer cell activation and inhibition;Lanier;Nat Immunol,2008

3. Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy;Aggarwal;Br J Haematol,2011

4. Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors;Epling-Burnette;Blood,2007

5. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes;Kiladjian;Leukemia,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation;Scientific Reports;2024-09-09

2. Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium;HemaSphere;2024-05

3. Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma;Journal of Clinical Medicine;2023-07-19

4. Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia;Blood Advances;2023-06-28

5. Checkpoint Inhibitors in Acute Myeloid Leukemia;Biomedicines;2023-06-15